Brimonidine Tartrate is a selective alpha-2 adrenergic agonist primarily used as an antiglaucoma agent to treat ocular hypertension and glaucoma by reducing intraocular pressure. To support robust analytical… Read more















Brimonidine Tartrate is a selective alpha-2 adrenergic agonist primarily used as an antiglaucoma agent to treat ocular hypertension and glaucoma by reducing intraocular pressure. To support robust analytical testing and rigorous quality control protocols, this category provides a comprehensive selection of Brimonidine Tartrate reference standards, including pharmacopeial and non-pharmacopeial impurities. These analytical materials, such as related compounds A, B, C, D, E, F, and G, are essential for impurity profiling, method validation, and the identification of degradation products in pharmaceutical manufacturing. Laboratories also rely on stable isotope-labelled compounds within this collection to serve as precise internal standards for mass spectrometry-based quantitative analysis. By utilizing these high-quality reference materials, researchers can ensure compliance with regulatory standards and maintain the accuracy of stability studies and ongoing quality assurance processes for this active pharmaceutical ingredient.